Literature DB >> 15655189

Gefitinib therapy for life-threatening laryngeal papillomatosis.

Bruce Bostrom1, James Sidman, Stephen Marker, Timothy Lander, Dennis Drehner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15655189     DOI： 10.1001/archotol.131.1.64

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN： 0886-4470


× No keyword cloud information.
  3 in total

1.  Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis.

Authors:  Matthew M Moldan; Bruce C Bostrom; Robert J Tibesar; Timothy A Lander; James D Sidman
Journal:  F1000Res       Date:  2013-10-03

Review 2.  Current and future management of recurrent respiratory papillomatosis.

Authors:  Ryan Ivancic; Hassan Iqbal; Brad deSilva; Quintin Pan; Laura Matrka
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-01-14

3.  Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis.

Authors:  Michael Mohr; Christoph Schliemann; Christoph Biermann; Lars-Henning Schmidt; Torsten Kessler; Joachim Schmidt; Karsten Wiebe; Klaus-Michael Müller; Thomas K Hoffmann; Andreas H Groll; Claudius Werner; Christina Kessler; Rainer Wiewrodt; Claudia Rudack; Wolfgang E Berdel
Journal:  Oncol Lett       Date:  2014-08-28       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.